Financials
- Market Capitalization 356.84 M
- Employee 149
- Founded 2018
- CEO N/A
- Website www.kyvernatx.com
- Headquarter Delaware, United States
- FIGI BBG00RCYMHR1
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.58
Fiyat/satışlar oranı
-6 934.07
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3081 | RLMD Relmada Therapeutics, Inc. - Common Stock | 3.36 USD | -4.27% | +3.07% | -24.32% | +74.09% | 358.41 M USD | ||
| 3084 | FENC Fennec Pharmaceuticals Inc. - Common Stock | 10.18 USD | -5.04% | -0.29% | -3.96% | +22.06% | 356.98 M USD | ||
| 3099 | IRD Opus Genetics, Inc. - Common Stock | 4.24 USD | -8.62% | -1.85% | -28.62% | +13.98% | 352.75 M USD | ||
| 3121 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.72 USD | -3.21% | -1.21% | -4.67% | +57.58% | 343.80 M USD |